Dr. Woodhead is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1501 N Campbell Ave
Tucson, AZ 85724Phone+1 312-942-6510- Is this information wrong?
Education & Training
- University of Arizona College of Medicine-TucsonResidency, Radiology-Diagnostic, 2011 - 2015
- Northwestern University The Feinberg School of MedicineClass of 2010
Certifications & Licensure
- AZ State Medical License 2016 - 2026
- IN State Medical License 2016 - 2023
- IL State Medical License 2010 - 2011
- American Board of Radiology Interventional Radiology and Diagnostic Radiology
Clinical Trials
- Real-Time Optical Biopsy in Improving Lung Cancer Diagnosis in Patients Undergoing Lung Biopsy Start of enrollment: 2017 Jul 26
Publications & Presentations
PubMed
- 5 citationsClinical and Dosimetric Implications of Calculating Lung Shunt Fraction for Hepatic Yttrium-90 Radioembolization Using SPECT/CT Versus Planar Scintigraphy.Lucas Struycken, Mikin V. Patel, Phillip H. Kuo, Charles Hennemeyer, Gregory Woodhead, H. McGregor> ;AJR. American Journal of Roentgenology. 2021 Oct 27
- 1 citationsSafety and Feasibility of a Novel Percutaneous Locoregional Injection Technique of Renal Cellular Therapy for Chronic Kidney Disease of Diabetes.Hyeon Yu, Paul D. Sonntag, Peter R. Bream, Michael Lazarowicz, Francis S. Nowakowski, Gregory Woodhead, Charles Hennemeyer, Ryan D. Muller, Rakesh Navuluri, Elaine M. ...> ;Kidney International Reports. 2021 Jun 19
- Using FDA-approved drugs as off-label fluorescent dyes for optical biopsies: from in silico design to ex vivo proof-of-conceptMichael C. Larson, Arthur F. Gmitro, Urs Utzinger, Andrew R. Rouse, Gregory Woodhead, Quinlan Carlson, Charles Hennemeyer, Jennifer K. Barton> ;Methods and Applications in Fluorescence. 2021 Jun 4
- Join now to see all
Press Mentions
- Idera Pharmaceuticals Presents Clinical Data from the ILLUMINATE-204 Trial of the Combination of Tilsotolimod and Ipilimumab for Anti-PD-1 Refractory Metastatic Melanoma at the 2018 American Society of Clinical Oncology (ASCO) Annual MeetingJune 4th, 2018
Grant Support
- B-Catenin/Tcf Signaling In Neural Cell Production &FateNational Institute Of Neurological Disorders And Stroke2005–2008
Hospital Affiliations
- Banner - University Medical Center TucsonTucson, Arizona
- Tucson VA Medical CenterTucson, Arizona
- Banner - University Medical Center SouthTucson, Arizona
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: